- 
                        Advancing Inhaled Drug Development Through Pharmacokinetic Modeling
                        31 Oct 2025 12:44 GMT
                         … inhaled drug development. Unlike traditional pharmacokinetic models that … outcomes. By integrating pharmacodynamic principles, researchers can …  of patients, developers can tailor treatments … advancements in mechanistic pharmacokinetic models represent a … 
- 
                        Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
                        31 Oct 2025 14:45 GMT
                         …  innovation pipeline by developing plant-based extract … portfolio of proprietary pharmaceutical and nutraceutical brands, …  (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, … broad line of pharmaceuticals and parapharmaceuticals, including … 
- 
                        CDMO Services Market for Pharma and Biotech: Growth Outlook and Industry Insights (2024–2034)
                        31 Oct 2025 14:00 GMT
                        
                           … drug development and manufacturing services to pharmaceutical and …  offering cell line development, process optimisation, … PCI Pharma Services
                          Rentschler Biopharma
                          Vetter Pharma
                           … ; formulation development
                          Analytical testing services
                          Process development …
                         
- 
                        PharmaJet® Signs Distribution Agreement with EVA Pharma to Provide Needle-free Injection Systems to Support Routine Polio Immunization in Egypt
                        31 Oct 2025 13:36 GMT
                        
                           …  EVA Pharma, the leading pharmaceutical company  … distributing, and promoting pharmaceutical products. “This collaboration …  of Business Development for PharmaJet. “This partnership … PharmaJet® and EVA Pharma Sign Distribution Agreement
                          PharmaJet® and EVA Pharma …
                         
- 
                        Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2025 Earnings Call Transcript
                        31 Oct 2025 12:12 GMT
                        
                           … October 29, 2025
                          Vanda Pharmaceuticals Inc. misses on  … us to discuss Vanda Pharmaceuticals’ third quarter 2025  … with Anaptys for the development and commercialization of imsidolimab … impacted by increased specialty pharmacy and specialty distributor  …
                         
- 
                        Calluna Pharma Announces U.S. FDA Orphan Drug Designation Granted to CAL101 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
                        31 Oct 2025 12:49 GMT
                        
                           … BOSTON--(BUSINESS WIRE)--Calluna Pharma AS, a clinical stage  …  of Clinical Operations and Pharmacovigilance. “Our ongoing IPF study … Designation to support the development and evaluation of new … efficacy and tolerability.
                          Calluna Pharma is incorporated in Oslo, …
                         
- 
                        BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q3 2025 Earnings Call Transcript
                        31 Oct 2025 12:12 GMT
                        
                           … Transcript October 29, 2025
                          BridgeBio Pharma, Inc. misses on earnings … successes in rare disease drug development. Both encaleret and BBP … amp;A Session
                          Follow Bridgebio Pharma Inc. (NASDAQ:BBIO)  … may now disconnect.
                          Follow Bridgebio Pharma Inc. (NASDAQ:BBIO)  …
                         
- 
                        Pepperl+Fuchs and Körber Combine MES and HMI Tech for the Pharma Industry
                        31 Oct 2025 12:40 GMT
                        
                           …  technologies to the pharmaceutical and life sciences  …  from initial process development through commercial production to … in line with the pharmaceutical industry regulatory requirements.  … and Körber.  
                          More pharmaceutical automation insights from Automation  …
                         
- 
                        HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
                        31 Oct 2025 12:00 GMT
                         …  2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA … program, currently in clinical development for the treatment of hepatitis … program, currently in clinical development for the treatment of  … virus. HOOKIPA has been developing the HB-400 and  … 
- 
                        Labaid plans 30 satellite cancer hospitals across Bangladesh, develops AI LUNA to make healthcare smarter
                        31 Oct 2025 11:51 GMT
                        
                           … my career with Labaid Pharmaceuticals. The factory was just … trials in collaboration with pharmaceutical companies and organise  … solutions?
                          Our own local developers are building these technologies, …  around 40 specialists, developing software solutions not only …